STAT3 and cancer: In prostate tumors, the activation of STAT3 signaling enhances glycolysis and proliferation in cancer cells, inhibits apoptosis, induces EMT mechanisms to facilitate cancer metastasis, and additionally activates drug resistance pathways (179).